quest13 - had just finished reading a Wapo article on COVID mutations and how they will likely extend not only the timeline of the virus but also, with another mutation or two, potentially limit the effectiveness of existing vaccines.  So, I agree with you that, suddenly, RVX's research/trials of apabetalone's effect on possibly mitigating the impact of the virus on us humans, that many of us initially figured was a bit of a lark, is taking on a whole new perspective.

If the COVID trial results are as promising as DM suspects then maybe we'll end up being the GameStop of biotech sooner than we all thought. Things are getting curiousor and curiousor.